US20070208385A1 - Surface stimulation for tremor control - Google Patents

Surface stimulation for tremor control Download PDF

Info

Publication number
US20070208385A1
US20070208385A1 US11/797,408 US79740807A US2007208385A1 US 20070208385 A1 US20070208385 A1 US 20070208385A1 US 79740807 A US79740807 A US 79740807A US 2007208385 A1 US2007208385 A1 US 2007208385A1
Authority
US
United States
Prior art keywords
subject
pairs
surface electrodes
brain
stimulation sites
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/797,408
Inventor
William Carroll
Richard Terrell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meagan Medical Inc
Original Assignee
International Rehabilitative Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by International Rehabilitative Sciences Inc filed Critical International Rehabilitative Sciences Inc
Priority to US11/797,408 priority Critical patent/US20070208385A1/en
Assigned to INTERNATIONAL REHABILITATIVE SCIENCES, INC. reassignment INTERNATIONAL REHABILITATIVE SCIENCES, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CARROLL, WILLIAM J., TERRELL, RICHARD M.
Publication of US20070208385A1 publication Critical patent/US20070208385A1/en
Assigned to MEAGAN MEDICAL, INC. reassignment MEAGAN MEDICAL, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: INTERNATIONAL REHABILITATIVE SCIENCES, INC.
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014External stimulators, e.g. with patch electrodes
    • A61N1/36025External stimulators, e.g. with patch electrodes for treating a mental or cerebral condition
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/323Interference currents, i.e. treatment by several currents summed in the body

Definitions

  • the present invention is generally related to tremor control, and more particularly, is related to an apparatus and methods for the electrical stimulation of the brain through skin surface stimulation of the peripheral nervous system for the treatment of movement disorders.
  • DBS deep brain stimulation
  • Essential Tremor is an involuntary movement, such as a shaking movement that is repeated over and over.
  • Essential Tremor usually affects the hands and head, although occasionally the feet or torso may also be affected.
  • Essential tremor which sometimes runs in families, is one of the most common types of tremor. It causes shaking that is most noticeable when a person is performing a task like lifting a cup or pointing at an object. The shaking does not occur when the person is not moving.
  • the tremor may also affect the person's voice. Medication can help reduce the shaking.
  • Tremors can also be caused by conditions or medications that affect the nervous system, including Parkinson's disease, liver failure, alcoholism, mercury or arsenic poisoning, lithium, and certain antidepressants.
  • DBS instead temporarily disables the cells by firing rapid pulses of electricity between four electrodes at the tip of a lead.
  • the lead is permanently implanted and connected to a pacemaker controller installed beneath the skin of the chest.
  • DBS utilizes electrodes that are usually implanted in one of three regions of the brain: the thalamic nucleus ventralis intermedius (Vim), the internal globus pallidus (GPi), and the subthalamic nucleus (STN) ( FIG. 1 ).
  • Vim thalamic nucleus ventralis intermedius
  • GPi internal globus pallidus
  • STN subthalamic nucleus
  • the challenge of DBS is the obvious drawback of having to undergo a neuro-surgical procedure and also to have the result of one or two electrodes implanted deep within the structures of the brain.
  • the present invention achieves tremor control through brain stimulation without the use of the invasive DBS electrodes.
  • Stimulation of peripheral nerves results in the excitation of some area of the brain (Thalmus, sub-cortical and Cortical areas).
  • the stimulation of sites on the surface of the skin produces effects of tremor control which are similar to the effects achieved by DBS for limited amounts of time.
  • Surface stimulation is achieved through the use of surface electrodes that are currently used for Muscle Stimulation or TENS. Following a 30-60 minute stimulation time, there is a residual decrease in tremor of at least 30-60 minutes.
  • the device can be worn under the clothing and activated while the decreased tremor period is desired.
  • PET Positron Emission Tomography
  • MEG Magnetoencephalography
  • fMRI fMRI scans
  • TENS Neuro-Muscular Stimulation
  • Ultra Sound Interferential Stimulation
  • PEMF Interferential Stimulation
  • EMF EMF
  • mechanical stimulation various types of mechanical stimulation.
  • Embodiments of the present invention provide an apparatus and methods for surface electrical stimulation of the peripheral nervous system at predetermined peripheral stimulation sites for the treatment of movement disorders.
  • the peripheral stimulation sites which are linked to specific areas of the brain, are initially traced using dermatome maps and then verified using PET scans, MEG scans, fMRI or other neural imaging devices.
  • the electrical stimulator may utilize an interferential current that has a base medium frequency alternating current between 1 KHz and 100 KHz.
  • An interferential current is set up between two circuits that are arranged in a cross-pattern on the subject's targeted area of stimulation. Where the circuits superimpose in a cross-pattern, the resultant beat frequency will be the difference between the frequencies of the two circuits and will usually range between 0-250 Hz and can be dynamic, and the amplitude will be additive and greater than either circuit alone.
  • Digital signal processors are used for improving the accuracy and reliability of digital signals that are used extensively in the communications field. Digital signal processing works by standardizing or clarifying the output of a digital signal.
  • the digital signal processor is used to shape multiple pulsatile waveforms to approximate the output of a sine-wave generator.
  • the digital signal processor is replaced with a field-programmable gate array (FPGA).
  • FPGA field-programmable gate array
  • a FPGA is an integrated circuit that can be programmed in the field after it is manufactured and therefore allows users to adjust the circuit output as the needs change. Both the DSP and the FPGA process a digital signal into a pseudo-sine-wave current waveform from the digital pulses generated by a pulse generator. The pseudo-sine-wave current waveform is transmitted through surface electrodes at a targeted area creating an interferential current.
  • the electrical stimulator may also use a standard TENS or NeuroMuscular stimulation waveform.
  • Such devices produce a pulsatile current with a square wave output, an amplitude range from 0-150 mA and a phase duration (pulse width) range of 1-500 ⁇ sec.
  • the frequency of such devices can range from 1 pulse per second (pps) to 2500 pps.
  • the devices can be set to various duty cycles (on and off times) from as little as 1 second to 30 minutes on, and an off time as little as 1 second to as long as several minutes.
  • the device can also be set to a continuous output without a duty cycle.
  • the device may utilize as little as one pair of electrodes, or multiple sets may be more effective depending on the condition of the patient.
  • peripheral stimulation sites are stimulated with the surface electrical stimulation device.
  • FIG. 1 is a drawing of the potential stimulation sites in the brain for deep brain stimulation for movement disorders
  • FIG. 2 is a drawing of a perspective view of an interferential current set up by two circuits
  • FIG. 3 is a drawing of a perspective view of an interferential current pattern indicating the current intensity level and area of beat frequency formation
  • FIG. 4 is a drawing of a stimulator with surface electrodes positioned at peripheral stimulation sites.
  • FIG. 1 shows the potential stimulation sites in the brain for deep brain stimulation via surface stimulation of the peripheral nervous system.
  • dermatome maps (not shown) of the peripheral nervous system, which can then be confirmed by PET scans (not shown) of the brain
  • peripheral surface stimulation sites 410 on a subject's skin surface are determined ( FIG. 4 ).
  • the stimulation of the peripheral surface stimulation sites 410 on the surface of the skin produces effects of tremor control which are similar to the effects achieved by DBS for limited amounts of time.
  • the excited peripheral nerves would in turn excite similar, but not necessarily, the same areas of the brain that are currently stimulated by DBS.
  • FIG. 2 shows a stimulator 200 for the electrical stimulation of the peripheral nerves for tremor control at the peripheral surface stimulation sites utilizing an interferential current 210 that has a base medium frequency alternating current between 1K-100 KHz.
  • a stimulator 200 is shown, for example, in U.S. Pat. No. 6,393,328, issued on May 21, 2002 to the assignee of the present application.
  • Other TENS, Neuromuscular stimulation devices, Ultrasound, Pulsed Electromagnetic Field generators, EMF generators and mechanical stimulation devices can also be utilized (not shown).
  • the interferential current 210 is set up between two circuits 218 , 220 , 418 , 420 that are arranged in a cross-pattern.
  • a first pair of surface electrodes 208 , 209 are positioned on a subject's skin surface at the peripheral surface stimulation site 410 on one set of diagonal corners of a targeted area 114 , 314 (see FIG. 3 ).
  • the targeted area is the peripheral nerve and surrounding area to be stimulated.
  • a second pair of surface electrodes 209 , 309 , and 408 is then positioned at the other set of diagonal corners of the targeted area 114 , 314 .
  • a digital signal processor 202 is connected to the first and second pairs of surface electrodes 208 , 209 ; 308 , 309 ; and 408 .
  • a signal-generating source 204 is connected to the digital signal processor 202 , a sine-wave-like waveform signal output 206 is created.
  • the digital signal processor 202 improves the accuracy and reliability of the digital signals.
  • the digital signal processor 202 processes the multiple pulses from the signal generating source 204 to approximate a sine-wave (pseudo-sine-wave or sine-wave-like).
  • the digital signal processor 202 generates individual pulses 206 of differing widths and resultant amplitudes. When those differing pulses 206 are driven into a transformer (not shown), the pseudo-sine-wave is produced.
  • a pulse generator 204 is connected to the input of the digital signal processor 202 and supplies a pulsed digital signal output 216 to the digital signal processor 202 .
  • the digital signal 216 is processed by the digital signal processor 202 to create a first circuit 218 and a second circuit 220 at the first and second pairs of surface electrodes 208 , 209 ; 308 , 309 ; and 408 , respectively.
  • the resultant beat frequency (which is preferably between 1 and 250 beats/second) will be the difference between the frequencies of the two circuits, and the amplitude will be additive and greater than either circuit alone ( FIG. 3 ).
  • Modulating the outputs of the first and second circuits 218 , 410 , 220 , 420 increases the area of the targeted stimulation ( FIG. 4 ).
  • the depth of modulation can vary from 0 to 100% and depends on the direction of the currents established by the first and second circuits 218 , 418 , 220 , 420 .
  • the maximum resultant amplitude and the deepest level of modulation is half-way between the two circuits (45° diagonally). (See FIG. 3 ).
  • the area of stimulation can be augmented by modulation of the amplitudes of the outputs of the two circuits.
  • FIG. 4 shows the stimulator 200 , 400 positioned to stimulate the two pairs of electrodes 208 , 209 ; 308 , 309 ; and 408 , at the predetermined peripheral surface stimulation sites 410 .
  • One pair of electrodes may be utilized if we are utilizing NMES or TENS outputs and it is deemed effective due to the condition, and predetermined with Neural Imaging studies.
  • the digital signal processor may be replaced with the FPGA.
  • DSP processors typically have only eight dedicated multipliers at their disposal
  • a higher end FPGA device can offer up to 224 dedicated multipliers plus additional logic element-based multipliers as needed. That allows for complex digital signal processing applications such as finite impulse response filters, forward error correction, modulation-demodulation, encryption and applications such as utilized in the present invention.

Abstract

Apparatus and methods for non-invasive electrical stimulation of the brain through skin surface stimulation of the peripheral nervous system as a treatment for movement disorders. Skin surface electrodes are positioned at predetermined peripheral surface stimulation sites on the skin surface using a variety of neural imaging techniques. A pulsatile electrical current is generated at the stimulation sites through a variety of standard electrical stimulation devices. Stimulation of the peripheral surface stimulation sites translates to electrical stimulation of a specific area of the brain.

Description

    CROSS REFERENCE TO RELATED APPLICATIONS
  • The present application is a continuation of the U.S. application Ser. No. 10/717,925, filed Nov. 23, 2003, which claims priority to Provisional Patent Application No. 60/428,281, filed Nov. 22, 2002, whose disclosure is hereby incorporated by reference in its entirety into the present disclosure.
  • FIELD OF THE INVENTION
  • The present invention is generally related to tremor control, and more particularly, is related to an apparatus and methods for the electrical stimulation of the brain through skin surface stimulation of the peripheral nervous system for the treatment of movement disorders.
  • BACKGROUND OF THE INVENTION
  • In the last decade, the use of deep brain stimulation (DBS) has demonstrated dramatic improvement in symptoms associated with movement disorders, including symptoms from Parkinson's disease (PD), Essential Tremor (ET) and dystonia.
  • Essential Tremor is an involuntary movement, such as a shaking movement that is repeated over and over. Essential Tremor usually affects the hands and head, although occasionally the feet or torso may also be affected. Essential tremor, which sometimes runs in families, is one of the most common types of tremor. It causes shaking that is most noticeable when a person is performing a task like lifting a cup or pointing at an object. The shaking does not occur when the person is not moving. The tremor may also affect the person's voice. Medication can help reduce the shaking. Tremors can also be caused by conditions or medications that affect the nervous system, including Parkinson's disease, liver failure, alcoholism, mercury or arsenic poisoning, lithium, and certain antidepressants.
  • Instead of destroying the overactive cells that cause symptoms from PD, for example, DBS instead temporarily disables the cells by firing rapid pulses of electricity between four electrodes at the tip of a lead. The lead is permanently implanted and connected to a pacemaker controller installed beneath the skin of the chest.
  • DBS utilizes electrodes that are usually implanted in one of three regions of the brain: the thalamic nucleus ventralis intermedius (Vim), the internal globus pallidus (GPi), and the subthalamic nucleus (STN) (FIG. 1). Some studies have shown that DBS has the best effect on tremors, when the Vim is stimulated. Rigidity and gait disturbances have shown improvements with stimulation of GPi and STN. The parameters of 130-185 Hz, 60 ms pulse width and 2.5 to 3.5 volts are most commonly utilized for DBS stimulation. DBS stimulation is typically pulsed intermittent stimulation having an on cycle of about a few seconds up to a minute, then an off cycle for about 30 seconds to several minutes.
  • The challenge of DBS is the obvious drawback of having to undergo a neuro-surgical procedure and also to have the result of one or two electrodes implanted deep within the structures of the brain.
  • The present invention achieves tremor control through brain stimulation without the use of the invasive DBS electrodes. Stimulation of peripheral nerves results in the excitation of some area of the brain (Thalmus, sub-cortical and Cortical areas). The stimulation of sites on the surface of the skin produces effects of tremor control which are similar to the effects achieved by DBS for limited amounts of time. Surface stimulation is achieved through the use of surface electrodes that are currently used for Muscle Stimulation or TENS. Following a 30-60 minute stimulation time, there is a residual decrease in tremor of at least 30-60 minutes. The device can be worn under the clothing and activated while the decreased tremor period is desired.
  • PET (Positron Emission Tomography) scans, a molecular medical imaging procedure that uses small amounts of radioactive pharmaceuticals to make images of the body's metabolic activity, Magnetoencephalography (MEG) scans and fMRI scans can be used to identify appropriate peripheral surface stimulation sites. Various types of stimulation can be used including TENS, Neuro-Muscular Stimulation, Ultra Sound, Interferential Stimulation, PEMF, EMF, and various types of mechanical stimulation.
  • Thus, a heretofore unaddressed need exists in the industry to address the aforementioned deficiencies and inadequacies associated with a neuro-surgical procedure and the implantation of at least one electrode deep within the structures of the brain.
  • SUMMARY OF THE INVENTION
  • Embodiments of the present invention provide an apparatus and methods for surface electrical stimulation of the peripheral nervous system at predetermined peripheral stimulation sites for the treatment of movement disorders.
  • In a preferred embodiment, the peripheral stimulation sites, which are linked to specific areas of the brain, are initially traced using dermatome maps and then verified using PET scans, MEG scans, fMRI or other neural imaging devices. The electrical stimulator may utilize an interferential current that has a base medium frequency alternating current between 1 KHz and 100 KHz. An interferential current is set up between two circuits that are arranged in a cross-pattern on the subject's targeted area of stimulation. Where the circuits superimpose in a cross-pattern, the resultant beat frequency will be the difference between the frequencies of the two circuits and will usually range between 0-250 Hz and can be dynamic, and the amplitude will be additive and greater than either circuit alone.
  • Digital signal processors (DSPs) are used for improving the accuracy and reliability of digital signals that are used extensively in the communications field. Digital signal processing works by standardizing or clarifying the output of a digital signal. In this embodiment, the digital signal processor is used to shape multiple pulsatile waveforms to approximate the output of a sine-wave generator. In another embodiment of the invention, the digital signal processor is replaced with a field-programmable gate array (FPGA). A FPGA is an integrated circuit that can be programmed in the field after it is manufactured and therefore allows users to adjust the circuit output as the needs change. Both the DSP and the FPGA process a digital signal into a pseudo-sine-wave current waveform from the digital pulses generated by a pulse generator. The pseudo-sine-wave current waveform is transmitted through surface electrodes at a targeted area creating an interferential current.
  • The electrical stimulator may also use a standard TENS or NeuroMuscular stimulation waveform. Such devices produce a pulsatile current with a square wave output, an amplitude range from 0-150 mA and a phase duration (pulse width) range of 1-500 μsec. The frequency of such devices can range from 1 pulse per second (pps) to 2500 pps. The devices can be set to various duty cycles (on and off times) from as little as 1 second to 30 minutes on, and an off time as little as 1 second to as long as several minutes. The device can also be set to a continuous output without a duty cycle. The device may utilize as little as one pair of electrodes, or multiple sets may be more effective depending on the condition of the patient.
  • Once identified, the peripheral stimulation sites are stimulated with the surface electrical stimulation device.
  • Other systems methods, features and advantages of the present invention will be or become apparent to one skilled in the art upon examination of the following drawings and detailed description. It is intended that all such additional systems, methods, features and advantages be included within this description, be within the scope of the present invention, and be protected by the accompanying claims.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • Many aspects of the invention can be better understood with reference to the following drawings. The components in the drawings are not necessarily to scale, emphasis instead being placed upon clearly illustrating the principles of the present invention. Moreover, in the drawings, like reference numerals designate corresponding parts throughout the several views.
  • FIG. 1 is a drawing of the potential stimulation sites in the brain for deep brain stimulation for movement disorders;
  • FIG. 2 is a drawing of a perspective view of an interferential current set up by two circuits;
  • FIG. 3 is a drawing of a perspective view of an interferential current pattern indicating the current intensity level and area of beat frequency formation; and
  • FIG. 4 is a drawing of a stimulator with surface electrodes positioned at peripheral stimulation sites.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
  • A preferred embodiment of the invention and modifications thereof will now be described with reference to the drawings.
  • FIG. 1 shows the potential stimulation sites in the brain for deep brain stimulation via surface stimulation of the peripheral nervous system. Using dermatome maps (not shown) of the peripheral nervous system, which can then be confirmed by PET scans (not shown) of the brain, peripheral surface stimulation sites 410 on a subject's skin surface are determined (FIG. 4). The stimulation of the peripheral surface stimulation sites 410 on the surface of the skin produces effects of tremor control which are similar to the effects achieved by DBS for limited amounts of time. The excited peripheral nerves would in turn excite similar, but not necessarily, the same areas of the brain that are currently stimulated by DBS.
  • FIG. 2 shows a stimulator 200 for the electrical stimulation of the peripheral nerves for tremor control at the peripheral surface stimulation sites utilizing an interferential current 210 that has a base medium frequency alternating current between 1K-100 KHz. Such a stimulator 200 is shown, for example, in U.S. Pat. No. 6,393,328, issued on May 21, 2002 to the assignee of the present application. Other TENS, Neuromuscular stimulation devices, Ultrasound, Pulsed Electromagnetic Field generators, EMF generators and mechanical stimulation devices can also be utilized (not shown).
  • The interferential current 210 is set up between two circuits 218, 220, 418, 420 that are arranged in a cross-pattern. A first pair of surface electrodes 208, 209 are positioned on a subject's skin surface at the peripheral surface stimulation site 410 on one set of diagonal corners of a targeted area 114, 314 (see FIG. 3). The targeted area is the peripheral nerve and surrounding area to be stimulated. A second pair of surface electrodes 209, 309, and 408, is then positioned at the other set of diagonal corners of the targeted area 114, 314. A digital signal processor 202 is connected to the first and second pairs of surface electrodes 208,209; 308,309; and 408. When a signal-generating source 204 is connected to the digital signal processor 202, a sine-wave-like waveform signal output 206 is created. The digital signal processor 202 improves the accuracy and reliability of the digital signals. The digital signal processor 202 processes the multiple pulses from the signal generating source 204 to approximate a sine-wave (pseudo-sine-wave or sine-wave-like). The digital signal processor 202 generates individual pulses 206 of differing widths and resultant amplitudes. When those differing pulses 206 are driven into a transformer (not shown), the pseudo-sine-wave is produced.
  • A pulse generator 204 is connected to the input of the digital signal processor 202 and supplies a pulsed digital signal output 216 to the digital signal processor 202. The digital signal 216 is processed by the digital signal processor 202 to create a first circuit 218 and a second circuit 220 at the first and second pairs of surface electrodes 208,209; 308,309; and 408, respectively. Where the first and second circuits 218, 220 superimpose, the resultant beat frequency (which is preferably between 1 and 250 beats/second) will be the difference between the frequencies of the two circuits, and the amplitude will be additive and greater than either circuit alone (FIG. 3).
  • Modulating the outputs of the first and second circuits 218, 410, 220, 420 increases the area of the targeted stimulation (FIG. 4). The depth of modulation can vary from 0 to 100% and depends on the direction of the currents established by the first and second circuits 218, 418, 220, 420. When the first and second circuits 218, 418, 220, 420 intersect at 90°, the maximum resultant amplitude and the deepest level of modulation is half-way between the two circuits (45° diagonally). (See FIG. 3). The area of stimulation can be augmented by modulation of the amplitudes of the outputs of the two circuits.
  • FIG. 4 shows the stimulator 200, 400 positioned to stimulate the two pairs of electrodes 208,209; 308,309; and 408, at the predetermined peripheral surface stimulation sites 410. One pair of electrodes may be utilized if we are utilizing NMES or TENS outputs and it is deemed effective due to the condition, and predetermined with Neural Imaging studies.
  • In an alternative embodiment, as described above, the digital signal processor may be replaced with the FPGA. Whereas DSP processors typically have only eight dedicated multipliers at their disposal, a higher end FPGA device can offer up to 224 dedicated multipliers plus additional logic element-based multipliers as needed. That allows for complex digital signal processing applications such as finite impulse response filters, forward error correction, modulation-demodulation, encryption and applications such as utilized in the present invention.
  • It should be emphasized that the above-described embodiments of the present invention, particularly, any “preferred” embodiments, are merely possible examples of implementations, merely set forth for a clear understanding on the principles of the invention. Many variations and modifications may be made to the above-described embodiment(s) of the invention without departing substantially from the spirit and principles of the invention. All such modifications and variations are intended to be included herein within the scope of this disclosure and the present invention, and protected by the following claims.

Claims (24)

1. A system for tremor control, comprising:
a stimulator, including:
a pulse generator for generating digital signal pulses,
a digital signal processor connected to said pulse generator for generating an approximate sine wave output that is further processed in first and second circuits, and
at least two pairs of surface electrodes connected to said digital signal processor and positioned at predetermined peripheral surface stimulation sites on a subject's skin surface; and
at least one neural image,
wherein said at least two pairs of surface electrodes stimulate the subject's brain, and
wherein the predetermined peripheral surface stimulation sites are determined based at least in part on the at least one neural image.
2. The system of claim 1, wherein said at least two pairs of surface electrodes connected to said digital signal processor produce an interferential current output waveform from said first and second circuits.
3. The system of claim 2, wherein said interferential current output waveform includes a base medium frequency of at least 1 KHz but no more than 100 KHz.
4. The system of claim 2, wherein said interferential current output waveform includes a resultant beat frequency of no more than 250 Hz.
5. The system of claim 1, wherein said at least two pairs of surface electrodes connected to said digital signal processor are positioned on the subject's skin surface using positron emission tomography and neural imaging devices to identify the peripheral surface stimulation sites.
6. The system of claim 1, wherein said at least two pairs of surface electrodes connected to said digital signal processor are positioned on the subject's skin surface using dermatome maps to identify the peripheral surface stimulation sites.
7. A system for tremor control, comprising:
a stimulator, including,
a pulse generator for generating digital signal pulses,
a field-programmable gate array connected to said pulse generator for processing the digital signal pulses to approximate a sine-wave output waveform that is further processed in first and second circuits, and
at least two pairs of surface electrodes connected to said field-programmable gate array and positioned at predetermined peripheral surface stimulation sites on a subject's skin surface; and
at least one neural image,
wherein said at least two pairs of surface electrodes stimulate the subject's brain, and
wherein the predetermined peripheral surface stimulation sites are determined based at least in part on the at least one neural image.
8. The system of claim 7, wherein said at least two pairs of surface electrodes connected to said field-programmable gate array produce an interferential current output waveform from said first and second circuits.
9. The system of claim 8, wherein said interferential current output waveform includes a base medium frequency of at least 1 KHz but no more than 100 KHz.
10. The system of claim 8, wherein said interferential current output waveform includes a resultant beat frequency of no more than 250 Hz.
11. The system of claim 7, wherein said at least two pairs of surface electrodes connected to said field-programmable gate array are positioned on the subject's skin surface using positron emission tomography and neural imaging devices to identify the peripheral surface stimulation sites.
12. The system of claim 7, wherein said at least two pairs of surface electrodes connected to said field-programmable gate array are positioned on the subject's skin surface using dermatome maps to identify the peripheral surface stimulation sites.
13. A system for tremor control, comprising:
a stimulator, including,
a pulse generator for generating electrical pulses, and
at least one pair of surface electrodes connected to said pulse generator and positioned at predetermined peripheral surface stimulation sites on a subject's skin surface; and
at least one neural image,
wherein said at least one pair of surface electrodes stimulate the subject's brain, and
wherein the predetermined peripheral surface stimulation sites are determined based at least in part on the at least one neural image.
14. The system of claim 13, wherein said at least one pair of surface electrodes connected to said pulse generator produce a pulsatile current with a square wave output.
15. The system of claim 14, wherein said pulsatile current includes an amplitude range from 0-150 mA and a pulse width of 1-500 μsec.
16. The system of claim 13, wherein said pulsatile current includes a frequency range from 1 pps to 2500 pps.
17. The system of claim 13, wherein said at least one pair of surface electrodes connected to said pulse generator are positioned on the subject's skin surface using positron emission tomography and neural imaging devices to identify the peripheral surface stimulation sites.
18. The system of claim 13, wherein said at least one pair of surface electrodes connected to said pulse generator are positioned on the subject's skin surface using dermatome maps to identify the peripheral surface stimulation sites.
19. The system of claim 1, wherein said at least two pairs of surface electrodes stimulate the subject's brain transcutaneously.
20. The system of claim 1, wherein said at least two pairs of surface electrodes stimulate the subject's brain percutaneously.
21. The system of claim 7, wherein said at least two pairs of surface electrodes stimulate the subject's brain transcutaneously.
22. The system of claim 7, wherein said at least two pairs of surface electrodes stimulate the subject's brain percutaneously.
23. The system of claim 13, wherein said at least one pair of surface electrodes stimulates the subject's brain transcutaneously.
24. The system of claim 13, wherein said at least one pair of surface electrodes stimulates the subject's brain percutaneously.
US11/797,408 2002-11-22 2007-05-03 Surface stimulation for tremor control Abandoned US20070208385A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/797,408 US20070208385A1 (en) 2002-11-22 2007-05-03 Surface stimulation for tremor control

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42828102P 2002-11-22 2002-11-22
US10/717,925 US7228178B2 (en) 2002-11-22 2003-11-21 Surface stimulation for tremor control
US11/797,408 US20070208385A1 (en) 2002-11-22 2007-05-03 Surface stimulation for tremor control

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/717,925 Continuation US7228178B2 (en) 2002-11-22 2003-11-21 Surface stimulation for tremor control

Publications (1)

Publication Number Publication Date
US20070208385A1 true US20070208385A1 (en) 2007-09-06

Family

ID=32393374

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/717,925 Expired - Fee Related US7228178B2 (en) 2002-11-22 2003-11-21 Surface stimulation for tremor control
US11/797,408 Abandoned US20070208385A1 (en) 2002-11-22 2007-05-03 Surface stimulation for tremor control

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US10/717,925 Expired - Fee Related US7228178B2 (en) 2002-11-22 2003-11-21 Surface stimulation for tremor control

Country Status (3)

Country Link
US (2) US7228178B2 (en)
AU (1) AU2003294454A1 (en)
WO (1) WO2004047911A2 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090167957A1 (en) * 2007-12-31 2009-07-02 Mi-Young Joo Video signal processing device and method of processing gradation
US10016600B2 (en) 2013-05-30 2018-07-10 Neurostim Solutions, Llc Topical neurological stimulation
US10806942B2 (en) 2016-11-10 2020-10-20 Qoravita LLC System and method for applying a low frequency magnetic field to biological tissues
US10953225B2 (en) 2017-11-07 2021-03-23 Neurostim Oab, Inc. Non-invasive nerve activator with adaptive circuit
US11077301B2 (en) 2015-02-21 2021-08-03 NeurostimOAB, Inc. Topical nerve stimulator and sensor for bladder control
US11229789B2 (en) 2013-05-30 2022-01-25 Neurostim Oab, Inc. Neuro activator with controller
US11458311B2 (en) 2019-06-26 2022-10-04 Neurostim Technologies Llc Non-invasive nerve activator patch with adaptive circuit
WO2023091391A1 (en) * 2021-11-18 2023-05-25 The Johns Hopkins University Interferential current stimulator for peripheral nerves
US11730958B2 (en) 2019-12-16 2023-08-22 Neurostim Solutions, Llc Non-invasive nerve activator with boosted charge delivery

Families Citing this family (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8788044B2 (en) 2005-01-21 2014-07-22 Michael Sasha John Systems and methods for tissue stimulation in medical treatment
US20070032827A1 (en) * 2005-08-08 2007-02-08 Katims Jefferson J Method and apparatus for producing therapeutic and diagnostic stimulation
US20110034782A1 (en) * 2005-11-30 2011-02-10 Fujikin Corporation Apparatus for body surface stimulation treatment, program for body surface stimulation treatment, and computer-readable recording medium having recorded the same
US20070191906A1 (en) * 2006-02-13 2007-08-16 Anand Iyer Method and apparatus for selective nerve stimulation
US8892200B2 (en) * 2006-06-19 2014-11-18 Highland Instruments, Inc. Systems and methods for stimulating tissue using focused energy
GB0709834D0 (en) * 2007-05-22 2007-07-04 Gillbe Ivor S Array stimulator
US8849407B1 (en) 2008-01-04 2014-09-30 Yuri P. Danilov Non-invasive neuromodulation (NINM) for rehabilitation of brain function
CA2747264A1 (en) * 2008-01-30 2009-08-06 Great Lakes Biosciences, Llc Brain-related chronic pain disorder treatment method and apparatus
EP2313148B1 (en) 2008-07-30 2013-08-21 Ecole Polytechnique Fédérale de Lausanne Apparatus for optimized stimulation of a neurological target
CA2743575C (en) 2008-11-12 2017-01-31 Ecole Polytechnique Federale De Lausanne Microfabricated neurostimulation device
CA2782710C (en) 2009-12-01 2019-01-22 Ecole Polytechnique Federale De Lausanne Microfabricated neurostimulation device and methods of making and using the same
EP2552536B1 (en) 2010-04-01 2016-06-08 Ecole Polytechnique Fédérale de Lausanne (EPFL) Device for interacting with neurological tissue
US8788045B2 (en) 2010-06-08 2014-07-22 Bluewind Medical Ltd. Tibial nerve stimulation
US9186504B2 (en) 2010-11-15 2015-11-17 Rainbow Medical Ltd Sleep apnea treatment
US9457186B2 (en) 2010-11-15 2016-10-04 Bluewind Medical Ltd. Bilateral feedback
WO2013111137A2 (en) 2012-01-26 2013-08-01 Rainbow Medical Ltd. Wireless neurqstimulatqrs
WO2014087337A1 (en) 2012-12-06 2014-06-12 Bluewind Medical Ltd. Delivery of implantable neurostimulators
BR112015017042B1 (en) 2013-01-21 2022-03-03 Cala Health, Inc Device to treat tremor
US9037268B2 (en) * 2013-05-03 2015-05-19 Eric A. Knight Skull-focused RF-based stimulation apparatus, system and method for treating patients with Alzheimer's disease or other dementia
US9486623B2 (en) 2014-03-05 2016-11-08 Rainbow Medical Ltd. Electrical stimulation of a pancreas
US11311718B2 (en) 2014-05-16 2022-04-26 Aleva Neurotherapeutics Sa Device for interacting with neurological tissue and methods of making and using the same
CN106455985B (en) 2014-05-16 2019-09-17 阿莱瓦神经治疗股份有限公司 With the device and production and preparation method thereof of nerve fiber interaction
JP6606105B2 (en) 2014-06-02 2019-11-13 カラ ヘルス,インコーポレイテッド System and method for peripheral nerve stimulation for treating tremor
US9474894B2 (en) 2014-08-27 2016-10-25 Aleva Neurotherapeutics Deep brain stimulation lead
US9403011B2 (en) 2014-08-27 2016-08-02 Aleva Neurotherapeutics Leadless neurostimulator
US10173061B2 (en) * 2014-10-08 2019-01-08 Massachusetts Institute Of Technology Methods and apparatus for stimulation of biological tissue
US9993640B2 (en) 2014-12-03 2018-06-12 Neurohabilitation Corporation Devices for delivering non-invasive neuromodulation to a patient
US9415210B2 (en) 2014-12-03 2016-08-16 Neurohabilitation Corporation Methods of manufacturing devices for the neurorehabilitation of a patient
US9227051B1 (en) 2014-12-03 2016-01-05 Neurohabilitation Corporation Devices for delivering non-invasive neuromodulation to a patient
US9789306B2 (en) 2014-12-03 2017-10-17 Neurohabilitation Corporation Systems and methods for providing non-invasive neurorehabilitation of a patient
USD753316S1 (en) 2014-12-03 2016-04-05 Neurohabilitation Corporation Non-invasive neurostimulation device
USD751214S1 (en) 2014-12-03 2016-03-08 Neurohabilitation Corporation Non-invasive neurostimulation device
US9415209B2 (en) 2014-12-03 2016-08-16 Neurohabilitation Corporation Methods of manufacturing devices for the neurorehabilitation of a patient
USD750267S1 (en) 2014-12-03 2016-02-23 Neurohabilitation Corporation Non-invasive neurostimulation device
USD750266S1 (en) 2014-12-03 2016-02-23 Neurohabilitation Corporation Non-invasive neurostimulation device
USD759830S1 (en) 2014-12-03 2016-06-21 Neurohabilitation Corporation Non-invasive neurostimulation device
USD749746S1 (en) 2014-12-03 2016-02-16 Neurohabilitation Corporation Non-invasive neurostimulation device
US9656060B2 (en) 2014-12-03 2017-05-23 Neurohabilitation Corporation Methods of manufacturing devices for the neurorehabilitation of a patient
US9272133B1 (en) 2014-12-03 2016-03-01 Neurohabilitation Corporation Methods of manufacturing devices for the neurorehabilitation of a patient
USD750265S1 (en) 2014-12-03 2016-02-23 Neurohabilitation Corporation Non-invasive neurostimulation device
US9616222B2 (en) 2014-12-03 2017-04-11 Neurohabilitation Corporation Systems for providing non-invasive neurorehabilitation of a patient
USD760397S1 (en) 2014-12-03 2016-06-28 Neurohabilitation Corporation Non-invasive neurostimulation device
USD752766S1 (en) 2014-12-03 2016-03-29 Neurohabilitation Corporation Non-invasive neurostimulation device
US9981127B2 (en) 2014-12-03 2018-05-29 Neurohabilitation Corporation Systems and methods for providing non-invasive neurorehabilitation of a patient
USD750794S1 (en) 2014-12-03 2016-03-01 Neurohabilitation Corporation Non-invasive neurostimulation device
USD750268S1 (en) 2014-12-03 2016-02-23 Neurohabilitation Corporation Non-invasive neurostimulation device
USD751722S1 (en) 2014-12-03 2016-03-15 Neurohabilitation Corporation Non-invasive neurostimulation device
USD751213S1 (en) 2014-12-03 2016-03-08 Neurohabilitation Corporation Non-invasive neurostimulation device
US9072889B1 (en) 2014-12-03 2015-07-07 Neurohabilitation Corporation Systems for providing non-invasive neurorehabilitation of a patient
USD752236S1 (en) 2014-12-03 2016-03-22 Neurohabilitation Corporation Non-invasive neurostimulation device
USD753315S1 (en) 2014-12-03 2016-04-05 Neurohabilitation Corporation Non-invasive neurostimulation device
USD750264S1 (en) 2014-12-03 2016-02-23 Neurohabilitation Corporation Non-invasive neurostimulation device
US9283377B1 (en) 2014-12-03 2016-03-15 Neurohabilitation Corporation Devices for delivering non-invasive neuromodulation to a patient
US10004896B2 (en) 2015-01-21 2018-06-26 Bluewind Medical Ltd. Anchors and implant devices
US9764146B2 (en) 2015-01-21 2017-09-19 Bluewind Medical Ltd. Extracorporeal implant controllers
US9597521B2 (en) 2015-01-21 2017-03-21 Bluewind Medical Ltd. Transmitting coils for neurostimulation
US11167139B2 (en) 2015-03-20 2021-11-09 Medtronic Sg, Llc Method and apparatus for multi modal electrical modulation of pain using composite electromagnetic fields
US10850102B2 (en) 2015-03-20 2020-12-01 Medtronic Sg, Llc Method and apparatus for multimodal electrical modulation of pain
AU2016235457B2 (en) 2015-03-20 2021-01-07 Medtronic Sg, Llc Method and apparatus for multimodal electrical modulation of pain
US10437335B2 (en) 2015-04-14 2019-10-08 John James Daniels Wearable electronic, multi-sensory, human/machine, human/human interfaces
CN107847730B (en) 2015-06-10 2021-03-16 卡拉健康公司 System and method for peripheral nerve stimulation to treat tremor with a detachable treatment and monitoring unit
US9782589B2 (en) 2015-06-10 2017-10-10 Bluewind Medical Ltd. Implantable electrostimulator for improving blood flow
CN108348746B (en) 2015-09-23 2021-10-12 卡拉健康公司 System and method for peripheral nerve stimulation in fingers or hands to treat hand tremor
US10105540B2 (en) 2015-11-09 2018-10-23 Bluewind Medical Ltd. Optimization of application of current
US9713707B2 (en) 2015-11-12 2017-07-25 Bluewind Medical Ltd. Inhibition of implant migration
US11344722B2 (en) 2016-01-21 2022-05-31 Cala Health, Inc. Systems, methods and devices for peripheral neuromodulation for treating diseases related to overactive bladder
WO2017134587A1 (en) 2016-02-02 2017-08-10 Aleva Neurotherapeutics, Sa Treatment of autoimmune diseases with deep brain stimulation
IL264116B2 (en) 2016-07-08 2024-01-01 Cala Health Inc Systems and methods for stimulating n nerves with exactly n electrodes and improved dry electrodes
US10124178B2 (en) 2016-11-23 2018-11-13 Bluewind Medical Ltd. Implant and delivery tool therefor
US11229787B2 (en) 2016-11-25 2022-01-25 Kinaptic, LLC Haptic human machine interface and wearable electronics methods and apparatus
CA3058786A1 (en) 2017-04-03 2018-10-11 Cala Health, Inc. Systems, methods and devices for peripheral neuromodulation for treating diseases related to overactive bladder
US20180353764A1 (en) 2017-06-13 2018-12-13 Bluewind Medical Ltd. Antenna configuration
US11723579B2 (en) 2017-09-19 2023-08-15 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement
US11717686B2 (en) 2017-12-04 2023-08-08 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement to facilitate learning and performance
US11478603B2 (en) 2017-12-31 2022-10-25 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement to enhance emotional response
EP3740274A4 (en) 2018-01-17 2021-10-27 Cala Health, Inc. Systems and methods for treating inflammatory bowel disease through peripheral nerve stimulation
US10702692B2 (en) 2018-03-02 2020-07-07 Aleva Neurotherapeutics Neurostimulation device
US11364361B2 (en) 2018-04-20 2022-06-21 Neuroenhancement Lab, LLC System and method for inducing sleep by transplanting mental states
EP3849410A4 (en) 2018-09-14 2022-11-02 Neuroenhancement Lab, LLC System and method of improving sleep
US11918811B2 (en) 2019-05-06 2024-03-05 Medtronic Sg, Llc Method and apparatus for multi modal or multiplexed electrical modulation of pain using composite electromagnetic fields
US11786694B2 (en) 2019-05-24 2023-10-17 NeuroLight, Inc. Device, method, and app for facilitating sleep
US11890468B1 (en) 2019-10-03 2024-02-06 Cala Health, Inc. Neurostimulation systems with event pattern detection and classification
GB2607441A (en) * 2021-05-12 2022-12-07 Steven Gerard Lenzie Robert Supplying a neurostimulation signal
US11400299B1 (en) 2021-09-14 2022-08-02 Rainbow Medical Ltd. Flexible antenna for stimulator

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5512057A (en) * 1994-11-14 1996-04-30 Medserv Group, Inc. Interferential stimulator for applying localized stimulation
US5702428A (en) * 1992-05-23 1997-12-30 Axelgaard Manufacturing Company, Ltd. Electrical stimulation for treatment of incontinence and other neuro-muscular disorders
US5938690A (en) * 1996-06-07 1999-08-17 Advanced Neuromodulation Systems, Inc. Pain management system and method
US6018675A (en) * 1998-05-22 2000-01-25 The Research Foundation Of State University Of New York Assembly and method for objectively measuring pain in a subject
US6027456A (en) * 1998-07-10 2000-02-22 Advanced Neuromodulation Systems, Inc. Apparatus and method for positioning spinal cord stimulation leads
US6161044A (en) * 1998-11-23 2000-12-12 Synaptic Corporation Method and apparatus for treating chronic pain syndromes, tremor, dementia and related disorders and for inducing electroanesthesia using high frequency, high intensity transcutaneous electrical nerve stimulation
US20020169485A1 (en) * 1995-10-16 2002-11-14 Neuropace, Inc. Differential neurostimulation therapy driven by physiological context
US20030050527A1 (en) * 2001-05-04 2003-03-13 Peter Fox Apparatus and methods for delivery of transcranial magnetic stimulation
US20030158587A1 (en) * 2000-12-12 2003-08-21 The Trustees Of The University Of Pennsylvania Adaptive method and apparatus for forecasting and controlling neurological disturbances under a multi-level control
US6647296B2 (en) * 1997-10-27 2003-11-11 Neuropace, Inc. Implantable apparatus for treating neurological disorders
US6937905B2 (en) * 2002-08-02 2005-08-30 International Rehabilitative Coion Sciences, Inc. Osteogenesis stimulator with digital signal processing
US7010351B2 (en) * 2000-07-13 2006-03-07 Northstar Neuroscience, Inc. Methods and apparatus for effectuating a lasting change in a neural-function of a patient

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5702428A (en) * 1992-05-23 1997-12-30 Axelgaard Manufacturing Company, Ltd. Electrical stimulation for treatment of incontinence and other neuro-muscular disorders
US5512057A (en) * 1994-11-14 1996-04-30 Medserv Group, Inc. Interferential stimulator for applying localized stimulation
US20020169485A1 (en) * 1995-10-16 2002-11-14 Neuropace, Inc. Differential neurostimulation therapy driven by physiological context
US5938690A (en) * 1996-06-07 1999-08-17 Advanced Neuromodulation Systems, Inc. Pain management system and method
US6647296B2 (en) * 1997-10-27 2003-11-11 Neuropace, Inc. Implantable apparatus for treating neurological disorders
US6018675A (en) * 1998-05-22 2000-01-25 The Research Foundation Of State University Of New York Assembly and method for objectively measuring pain in a subject
US6027456A (en) * 1998-07-10 2000-02-22 Advanced Neuromodulation Systems, Inc. Apparatus and method for positioning spinal cord stimulation leads
US6161044A (en) * 1998-11-23 2000-12-12 Synaptic Corporation Method and apparatus for treating chronic pain syndromes, tremor, dementia and related disorders and for inducing electroanesthesia using high frequency, high intensity transcutaneous electrical nerve stimulation
US7010351B2 (en) * 2000-07-13 2006-03-07 Northstar Neuroscience, Inc. Methods and apparatus for effectuating a lasting change in a neural-function of a patient
US20080161881A1 (en) * 2000-07-13 2008-07-03 Northstar Neuroscience, Inc. Methods and apparatus for effectuating a lasting change in a neural-function of a patient
US20030158587A1 (en) * 2000-12-12 2003-08-21 The Trustees Of The University Of Pennsylvania Adaptive method and apparatus for forecasting and controlling neurological disturbances under a multi-level control
US20030050527A1 (en) * 2001-05-04 2003-03-13 Peter Fox Apparatus and methods for delivery of transcranial magnetic stimulation
US6937905B2 (en) * 2002-08-02 2005-08-30 International Rehabilitative Coion Sciences, Inc. Osteogenesis stimulator with digital signal processing

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8189013B2 (en) * 2007-12-31 2012-05-29 Samsung Sdi Co., Ltd. Video signal processing device and method of processing gradation
US20090167957A1 (en) * 2007-12-31 2009-07-02 Mi-Young Joo Video signal processing device and method of processing gradation
US11229789B2 (en) 2013-05-30 2022-01-25 Neurostim Oab, Inc. Neuro activator with controller
US10016600B2 (en) 2013-05-30 2018-07-10 Neurostim Solutions, Llc Topical neurological stimulation
US10307591B2 (en) 2013-05-30 2019-06-04 Neurostim Solutions, Llc Topical neurological stimulation
US10918853B2 (en) 2013-05-30 2021-02-16 Neurostim Solutions, Llc Topical neurological stimulation
US10946185B2 (en) 2013-05-30 2021-03-16 Neurostim Solutions, Llc Topical neurological stimulation
US11291828B2 (en) 2013-05-30 2022-04-05 Neurostim Solutions LLC Topical neurological stimulation
US11077301B2 (en) 2015-02-21 2021-08-03 NeurostimOAB, Inc. Topical nerve stimulator and sensor for bladder control
US10806942B2 (en) 2016-11-10 2020-10-20 Qoravita LLC System and method for applying a low frequency magnetic field to biological tissues
US11344741B2 (en) 2016-11-10 2022-05-31 Qoravita LLC System and method for applying a low frequency magnetic field to biological tissues
US11826579B2 (en) 2016-11-10 2023-11-28 Mannavibes Inc. System and method for applying a low frequency magnetic field to biological tissues
US10953225B2 (en) 2017-11-07 2021-03-23 Neurostim Oab, Inc. Non-invasive nerve activator with adaptive circuit
US11458311B2 (en) 2019-06-26 2022-10-04 Neurostim Technologies Llc Non-invasive nerve activator patch with adaptive circuit
US11730958B2 (en) 2019-12-16 2023-08-22 Neurostim Solutions, Llc Non-invasive nerve activator with boosted charge delivery
WO2023091391A1 (en) * 2021-11-18 2023-05-25 The Johns Hopkins University Interferential current stimulator for peripheral nerves

Also Published As

Publication number Publication date
AU2003294454A8 (en) 2004-06-18
WO2004047911A2 (en) 2004-06-10
US7228178B2 (en) 2007-06-05
US20040138722A1 (en) 2004-07-15
AU2003294454A1 (en) 2004-06-18
WO2004047911A3 (en) 2004-07-01

Similar Documents

Publication Publication Date Title
US7228178B2 (en) Surface stimulation for tremor control
US10953227B2 (en) Spinal cord stimulation with interferential current
US10918867B2 (en) Systems and methods for producing asynchronous neural responses to treat pain and/or other patient conditions
US20070088404A1 (en) Methods and systems for improving neural functioning, including cognitive functioning and neglect disorders
US20070255085A1 (en) Device and Method for Non-Invasive, Localized Neural Stimulation Utilizing Hall Effect Phenomenon
JP2018527066A (en) Spinal cord stimulation with interference current
JP7162225B2 (en) Crossed short-pulse electrical stimulation of the brain
JP2007501067A (en) Apparatus and method for applying neural stimulation to patient
JP6937767B2 (en) Devices and Methods for Effective Invasive Amplitude Modulation Nerve Stimulation
US20220331602A1 (en) Apparatus and method
WO2023003501A1 (en) Device and method for stimulating a target area
CN114796875B (en) Electromagnetic stimulation method, device, equipment and readable storage medium
US20060041284A1 (en) Electrical stimulation system and method for stimulating nerve tissue in the brain using a stimulation lead having a tip electrode, having at least five electrodes, or both
US11944817B2 (en) Variable amplitude signals for neurological therapy, and associated systems and methods
Kagan et al. Magnetic stimulation of mammalian peripheral nerves in vivo: an alternative to functional electrical stimulation
CN110870946A (en) Device for stimulating the reins and/or the medullary veins and/or the retroflexion in the brain
Grossman 16 Noninvasive deep brain stimulation via delivery of temporally interfering electric fields
US20230414955A1 (en) Closed-Loop Technique to Reduce Electrosensation While Treating a Subject Using Alternating Electric Fields
WO2024050557A2 (en) Treatment of tissue using electrical stimulation pulses based on non-canceled electrical output

Legal Events

Date Code Title Description
AS Assignment

Owner name: INTERNATIONAL REHABILITATIVE SCIENCES, INC., WASHI

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:CARROLL, WILLIAM J.;TERRELL, RICHARD M.;REEL/FRAME:019324/0290

Effective date: 20031216

AS Assignment

Owner name: MEAGAN MEDICAL, INC.,WASHINGTON

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:INTERNATIONAL REHABILITATIVE SCIENCES, INC.;REEL/FRAME:024120/0771

Effective date: 20090430

Owner name: MEAGAN MEDICAL, INC., WASHINGTON

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:INTERNATIONAL REHABILITATIVE SCIENCES, INC.;REEL/FRAME:024120/0771

Effective date: 20090430

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION